The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function.

Area of Science:

• Molecular Biology
• Hematology
• Genetics

Background:

• Genetic factors are implicated in thrombotic disease risk.
• Genome-wide association studies have identified SLC44A2 as a potential regulator of thrombosis.

Purpose of the Study:

• To investigate the role of Slc44a2 in platelet activation and thrombosis.
• To elucidate the mechanism by which Slc44a2 influences thrombosis via mitochondrial energetics.

Main Methods:

• Comparison of Slc44a2 null (Slc44a2(KO)) mice with wild-type (Slc44a2(WT)) controls.
• Analysis of platelet activation in response to thrombin.
• Assessment of mitochondrial choline transport and metabolism.
• Measurement of ATP levels in platelets and rescue experiments with ADP.

Main Results:

• Slc44a2(KO) mice exhibited prolonged bleeding times and delayed thrombosis.
• Platelets from Slc44a2(KO) mice showed impaired activation.
• Slc44a2 was found to mediate mitochondrial choline transport, essential for oxygen consumption and ATP production.
• Platelets lacking Slc44a2 had reduced ATP levels and activation defects, which were partially restored by exogenous ADP.

Conclusions:

• Mitochondria require choline for optimal function.
• Mitochondrial metabolism is crucial for platelet activation.
• Slc44a2 plays a significant role in thrombosis by regulating mitochondrial energetics and platelet function.